PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930079
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930079
Liquid Biopsy Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of liquid biopsy Market
The global liquid biopsy market was valued at USD 11.66 billion in 2025 and is projected to grow to USD 14.23 billion in 2026, reaching a substantial USD 106.49 billion by 2034. The market is expected to expand at a compound annual growth rate (CAGR) of 28.61% during the forecast period. This rapid growth is primarily driven by the rising prevalence of cancer, increasing demand for non-invasive diagnostic techniques, and advancements in molecular diagnostics.
Liquid biopsy refers to the detection and analysis of circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), circulating tumor cells, and biomarkers from biological fluids such as blood, cerebrospinal fluid, and amniotic fluid. These tests provide a minimally invasive alternative to traditional tissue biopsies for cancer diagnosis, prognosis, and therapy selection.
Market Size & Value (As per Report Year)
- 2025 Market Size: USD 11.66 billion
- 2026 Market Size: USD 14.23 billion
- 2034 Forecast Market Size: USD 106.49 billion
Key Growth Drivers
The rising global burden of cancer is a major factor fueling market growth. According to ICMR data, cancer incidence in India increased from 1.39 million in 2020 to 1.46 million in 2022, reflecting a broader global trend. This surge has increased the demand for early screening, disease monitoring, and precision oncology solutions.
In addition, liquid biopsy plays a critical role in non-invasive prenatal testing (NIPT), driven by the increasing prevalence of chromosomal abnormalities such as Down syndrome. Government-supported screening initiatives and growing awareness of early disease detection have further boosted adoption.
Regulatory approvals from agencies such as the U.S. FDA for advanced cancer detection assays, along with continuous clinical research and innovation, are significantly supporting market expansion.
Market Restraints
Despite its advantages, the market faces challenges related to high test costs and reimbursement limitations. In the U.S., liquid biopsy tests can cost over USD 2,000 per test, making them less accessible for routine screening. Additionally, reimbursement restrictions-especially for early-stage cancer screening-limit broader adoption, particularly in developing economies such as India and China.
Segmentation Analysis
By Product:
Kits & reagents dominate the market, accounting for 80.08% share in 2026, due to frequent product launches and approvals for ctDNA and NIPT assays. Instruments are expected to grow at a moderate pace, supported by technological advancements in PCR and NGS platforms.
By Application:
Non-invasive prenatal testing (NIPT) held the largest share at 68.69% in 2026, driven by rising prenatal screening demand. The oncology segment is expected to grow at a higher CAGR, supported by increasing use in cancer diagnosis, therapy monitoring, and recurrence detection.
By End User:
Hospitals dominated the market with a 75.01% share in 2026, owing to high patient footfall and increasing adoption of cancer and prenatal tests. Clinical laboratories are expected to register notable growth due to expanding diagnostic infrastructure.
Regional Insights
North America dominated the global liquid biopsy market with a 54.57% share in 2025, driven by strong R&D investment, early adoption of precision oncology, and favorable reimbursement frameworks.
Europe follows due to government-led cancer screening programs and rising funding for diagnostic innovation.
Asia Pacific is expected to witness the fastest growth, supported by rising cancer prevalence, expanding healthcare access, and growing adoption of NIPT in countries such as China, Japan, and India.
Competitive Landscape
Key players include Guardant Health, Foundation Medicine, Natera, Illumina, Roche, Thermo Fisher Scientific, QIAGEN, and Bio-Rad Laboratories. Companies are focusing on strategic collaborations, clinical trials, and product innovations to strengthen their market presence.
Conclusion
The global liquid biopsy market is poised for strong long-term growth, expanding from USD 11.66 billion in 2025 to USD 106.49 billion by 2034. Rising cancer incidence, increasing preference for non-invasive diagnostics, and advancements in molecular testing technologies are the key growth catalysts. Although high costs and reimbursement challenges remain, continuous innovation, regulatory approvals, and expanding clinical applications are expected to drive widespread adoption, positioning liquid biopsy as a cornerstone of future precision medicine.
Growth Rate CAGR of 28.61% from 2026-2034
Segmentation By Product
- Kits & Reagents
- Instruments
By Application
- Non-invasive Prenatal Testing (NIPT)
- Oncology
- Others
By End User
- Hospitals
- Clinical Laboratories
- Others
By Region
- North America (By Product, By Application, By End User, and By Country)
- U.S. (By Application)
- Canada (By Application)
- Europe (By Product, By Application, By End User, and By Country/ Sub-region)
- Germany (By Application)
- U.K. (By Application)
- France (By Application)
- Italy (By Application)
- Spain (By Application)
- Rest of Europe (By Application)
- Asia Pacific (By Product, By Application, By End User, and By Country/ Sub-region)
- Japan (By Application)
- China (By Application)
- India (By Application)
- Australia (By Application)
- Southeast Asia (By Application)
- Rest of Asia Pacific (By Application)
- Latin America (By Product, By Application, By End User, and By Country/ Sub-region)
- Brazil (By Application)
- Mexico (By Application)
- Rest of Latin America (By Application)
- Middle East & Africa (By Product, By Application, By End User, and By Country/ Sub-region)
- GCC (By Application)
- South Africa (By Application)
- Rest of Middle East & Africa (By Application)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Cancer, By Key Countries, 2025
- 4.2. Key Industry Developments - Mergers, Partnerships, & Acquisitions
- 4.3. New Product Launches, By Key Players
- 4.4. Impact of COVID-19 on the Market
5. Global Liquid Biopsy Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Kits & Reagents
- 5.1.2. Instruments
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Non-invasive Prenatal Testing (NIPT)
- 5.2.2. Oncology
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - By End User
- 5.3.1. Hospitals
- 5.3.2. Clinical Laboratories
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East and Africa
6. North America Liquid Biopsy Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Kits & Reagents
- 6.1.2. Instruments
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Non-invasive Prenatal Testing (NIPT)
- 6.2.2. Oncology
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast - By End User
- 6.3.1. Hospitals
- 6.3.2. Clinical Laboratories
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.1.1. By Application
- 6.4.2. Canada
- 6.4.2.1. By Application
- 6.4.1. U.S.
7. Europe Liquid Biopsy Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Kits & Reagents
- 7.1.2. Instruments
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Non-invasive Prenatal Testing (NIPT)
- 7.2.2. Oncology
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast - By End User
- 7.3.1. Hospitals
- 7.3.2. Clinical Laboratories
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.4.1. U.K.
- 7.4.1.1. By Application
- 7.4.2. Germany
- 7.4.2.1. By Application
- 7.4.3. France
- 7.4.3.1. By Application
- 7.4.4. Spain
- 7.4.4.1. By Application
- 7.4.5. Italy
- 7.4.5.1. By Application
- 7.4.6. Rest of Europe
- 7.4.6.1. By Application
- 7.4.1. U.K.
8. Asia Pacific Liquid Biopsy Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Kits & Reagents
- 8.1.2. Instruments
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Non-invasive Prenatal Testing (NIPT)
- 8.2.2. Oncology
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast - By End User
- 8.3.1. Hospitals
- 8.3.2. Clinical Laboratories
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.4.1. Japan
- 8.4.1.1. By Application
- 8.4.2. China
- 8.4.2.1. By Application
- 8.4.3. India
- 8.4.3.1. By Application
- 8.4.4. Australia
- 8.4.4.1. By Application
- 8.4.5. Southeast Asia
- 8.4.5.1. By Application
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Application
- 8.4.1. Japan
9. Latin America Liquid Biopsy Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Kits & Reagents
- 9.1.2. Instruments
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Non-invasive Prenatal Testing (NIPT)
- 9.2.2. Oncology
- 9.2.3. Others
- 9.3. Market Analysis, Insights and Forecast - By End User
- 9.3.1. Hospitals
- 9.3.2. Clinical Laboratories
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Application
- 9.4.2. Mexico
- 9.4.2.1. By Application
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Application
- 9.4.1. Brazil
10. Middle East & Africa Liquid Biopsy Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Kits & Reagents
- 10.1.2. Instruments
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Non-invasive Prenatal Testing (NIPT)
- 10.2.2. Oncology
- 10.2.3. Others
- 10.3. Market Analysis, Insights and Forecast - By End User
- 10.3.1. Hospitals
- 10.3.2. Clinical Laboratories
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.4.1. GCC
- 10.4.1.1. By Application
- 10.4.2. South Africa
- 10.4.2.1. By Application
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Application
- 10.4.1. GCC
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Guardant Health
- 11.2.1.1. Overview
- 11.2.1.2. Products & Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. PERSONALIS, INC.
- 11.2.2.1. Overview
- 11.2.2.2. Products & Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. FOUNDATION MEDICINE, INC.
- 11.2.3.1. Overview
- 11.2.3.2. Products & Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Natera, Inc.
- 11.2.4.1. Overview
- 11.2.4.2. Products & Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Illumina, Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products & Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. F. Hoffmann-La Roche Ltd
- 11.2.6.1. Overview
- 11.2.6.2. Products & Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Menarini Silicon Biosystems, Inc.
- 11.2.7.1. Overview
- 11.2.7.2. Products & Services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Thermo Fisher Scientific Inc.
- 11.2.8.1. Overview
- 11.2.8.2. Products & Services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. QIAGEN
- 11.2.9.1. Overview
- 11.2.9.2. Products & Services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Bio-Rad Laboratories, Inc.
- 11.2.10.1. Overview
- 11.2.10.2. Products & Services
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.1. Guardant Health
List of Tables
- Table 01: Global Liquid Biopsy Market Revenue (USD billion) Forecast, By Product, 2021-2034
- Table 02: Global Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 03: Global Liquid Biopsy Market Revenue (USD billion) Forecast, By End User, 2021-2034
- Table 04: Global Liquid Biopsy Market Revenue (USD billion) Forecast, By Region, 2021-2034
- Table 05: North America Liquid Biopsy Market Revenue (USD billion) Forecast, By Product, 2021-2034
- Table 06: North America Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 07: North America Liquid Biopsy Market Revenue (USD billion) Forecast, By End User 2021-2034
- Table 08: North America Liquid Biopsy Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 09: U.S. Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 10: Canada Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 11: Europe Liquid Biopsy Market Revenue (USD billion) Forecast, By Product, 2021-2034
- Table 12: Europe Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 13: Europe Liquid Biopsy Market Revenue (USD billion) Forecast, By End User 2021-2034
- Table 14: Europe Liquid Biopsy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 15: Germany Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 16: Spain Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 17: France Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 18: Italy Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 19: U.K. Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 20: Rest of Europe Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 21: Asia Pacific Liquid Biopsy Market Revenue (USD billion) Forecast, By Product, 2021-2034
- Table 22: Asia Pacific Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 23: Asia Pacific Liquid Biopsy Market Revenue (USD billion) Forecast, By End User 2021-2034
- Table 24: Asia Pacific Liquid Biopsy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 25: China Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 26: India Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 27: Japan Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 28: Australia Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 29: Southeast Asia Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 30: Rest of Asia Pacific Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 31: Latin America Liquid Biopsy Market Revenue (USD billion) Forecast, By Product, 2021-2034
- Table 32: Latin America Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 33: Latin America Liquid Biopsy Market Revenue (USD billion) Forecast, By End User 2021-2034
- Table 34: Latin America Liquid Biopsy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 35: Brazil Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 36: Mexico Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 37: Rest of Latin America Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 38: Middle East & Africa Liquid Biopsy Market Revenue (USD billion) Forecast, By Product, 2021-2034
- Table 39: Middle East & Africa Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 40: Middle East & Africa Liquid Biopsy Market Revenue (USD billion) Forecast, By End User 2021-2034
- Table 41: Middle East & Africa Liquid Biopsy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 42: GCC Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 43: South Africa Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 44: Rest of Middle East & Africa Liquid Biopsy Market Revenue (USD billion) Forecast, By Application, 2021-2034
List of Figures
- Figure 01: Global Liquid Biopsy Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 02: Global Liquid Biopsy Market Value Share (%), By Product, 2025 & 2034
- Figure 03: Global Liquid Biopsy Market Value Share (%), By Application, 2025 & 2034
- Figure 04: Global Liquid Biopsy Market Value Share (%), By End User, 2025 & 2034
- Figure 05: Global Liquid Biopsy Market Value Share (%), By Region, 2025 & 2034
- Figure 06: North America Liquid Biopsy Market Value (USD billion), By Product, 2025 & 2034
- Figure 07: North America Liquid Biopsy Market Value Share (%), By Product, 2025
- Figure 08: North America Liquid Biopsy Market Value (USD billion), By Application, 2025 & 2034
- Figure 09: North America Liquid Biopsy Market Value Share (%), By Application, 2025
- Figure 10: North America Liquid Biopsy Market Value (USD billion), by End User, 2025 & 2034
- Figure 11: North America Liquid Biopsy Market Value Share (%), by End User, 2025
- Figure 12: North America Liquid Biopsy Market Value (USD billion), by Country, 2025 & 2034
- Figure 13: North America Liquid Biopsy Market Value Share (%), by Country, 2025
- Figure 14: Europe Liquid Biopsy Market Value (USD billion), By Product, 2025 & 2034
- Figure 15: Europe Liquid Biopsy Market Value Share (%), By Product, 2025
- Figure 16: Europe Liquid Biopsy Market Value (USD billion), By Application, 2025 & 2034
- Figure 17: Europe Liquid Biopsy Market Value Share (%), By Application, 2025
- Figure 18: Europe Liquid Biopsy Market Value (USD billion), by End User, 2025 & 2034
- Figure 19: Europe Liquid Biopsy Market Value Share (%), by End User, 2025
- Figure 20: Europe Liquid Biopsy Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
- Figure 21: Europe Liquid Biopsy Market Value Share (%), by Country/ Sub-region, 2025
- Figure 22: Asia Pacific Liquid Biopsy Market Value (USD billion), By Product, 2025 & 2034
- Figure 23: Asia Pacific Liquid Biopsy Market Value Share (%), By Product, 2025
- Figure 24: Asia Pacific Liquid Biopsy Market Value (USD billion), By Application, 2025 & 2034
- Figure 25: Asia Pacific Liquid Biopsy Market Value Share (%), By Application, 2025
- Figure 26: Asia Pacific Liquid Biopsy Market Value (USD billion), by End User, 2025 & 2034
- Figure 27: Asia Pacific Liquid Biopsy Market Value Share (%), by End User, 2025
- Figure 28: Asia Pacific Liquid Biopsy Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Liquid Biopsy Market Value Share (%), by Country/ Sub-region, 2025
- Figure 30: Latin America Liquid Biopsy Market Value (USD billion), By Product, 2025 & 2034
- Figure 31: Latin America Liquid Biopsy Market Value Share (%), By Product, 2025
- Figure 32: Latin America Liquid Biopsy Market Value (USD billion), By Application, 2025 & 2034
- Figure 33: Latin America Liquid Biopsy Market Value Share (%), By Application, 2025
- Figure 34: Latin America Liquid Biopsy Market Value (USD billion), by End User, 2025 & 2034
- Figure 35: Latin America Liquid Biopsy Market Value Share (%), by End User, 2025
- Figure 36: Latin America Liquid Biopsy Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
- Figure 37: Latin America Liquid Biopsy Market Value Share (%), by Country/ Sub-region, 2025
- Figure 38: Middle East & Africa Liquid Biopsy Market Value (USD billion), By Product, 2025 & 2034
- Figure 39: Middle East & Africa Liquid Biopsy Market Value Share (%), By Product, 2025
- Figure 40: Middle East & Africa Liquid Biopsy Market Value (USD billion), By Application, 2025 & 2034
- Figure 41: Middle East & Africa Liquid Biopsy Market Value Share (%), By Application, 2025
- Figure 42: Middle East & Africa Liquid Biopsy Market Value (USD billion), by End User, 2025 & 2034
- Figure 43: Middle East & Africa Liquid Biopsy Market Value Share (%), by End User, 2025
- Figure 44: Middle East & Africa Liquid Biopsy Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
- Figure 45: Middle East & Africa Liquid Biopsy Market Value Share (%), by Country/ Sub-region, 2025
- Figure 46: Global Liquid Biopsy Market Share (%), 2025
